[Latest] Global Pharmaceutical Membrane Filtration Market Size/Share Worth USD 27,620 Million by 2033 at a 13.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
21. November 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Pharmaceutical Membrane Filtration Market Size, Trends and Insights By Product...
Human Papillomavirus (HPV) Vaccines Industry, Forecast to 2032 - HPV Vaccine Market Set to Nearly Triple by 2032 as U.S. & Europe Lead; Japan & India Emerge as Key Growth Regions
07. November 2024 09:33 ET
|
Research and Markets
Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Human Papillomavirus (HPV) Vaccine Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The human...
United States Influenza Vaccines Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts 2019-2023 & 2024-2033
29. Oktober 2024 10:59 ET
|
Research and Markets
Dublin, Oct. 29, 2024 (GLOBE NEWSWIRE) -- The "United States Influenza Vaccines Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to...
BlueWillow Biologics to Present Significant Progress on Its Novel Intranasal Vaccine Technology at World Vaccine Congress Europe
28. Oktober 2024 08:05 ET
|
BlueWillow Biologics
ANN ARBOR, Mich., Oct. 28, 2024 (GLOBE NEWSWIRE) -- BlueWillow Biologics, Inc., a clinical-stage biotech company pioneering the future of intranasal vaccines, today announced that the company will...
Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials
09. Oktober 2024 08:00 ET
|
Evaxion Biotech
Data from three separate clinical trials documents the strong ability of the AI-Immunology™ platform to select clinically relevant vaccine targets Strongest outcomes are generated by the top-ranked...
2024 Research | Vaccine Delivery Devices Market Poised for Remarkable Growth, Expected to Reach $9.45 Billion by 2028
04. Oktober 2024 09:06 ET
|
Research and Markets
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Delivery Devices Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. In a significant development for the...
Human Combination Vaccines Market Through 2028
04. Oktober 2024 06:54 ET
|
Research and Markets
Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "Global Human Combination Vaccines Market 2024-2028" report has been added to ResearchAndMarkets.com's offering.The human combination vaccines market...
Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platform
03. Oktober 2024 08:00 ET
|
Evaxion Biotech
Improved precision of the AI-Immunology™ platform in predicting clinically relevant vaccine targets boosts the potential of its AI-derived vaccine candidates The improvement has been achieved through...
Evaxion significantly expands vaccine development collaboration with MSD
26. September 2024 07:30 ET
|
Evaxion Biotech
Agreement provides MSD with options to license Evaxion’s preclinical, AI-designed vaccine candidates EVX-B2 and EVX-B3Evaxion will host a conference call and webcast to discuss the agreement on...
mRNA Vaccine and Therapeutics Market Global Report to 2035, with Profiles of Arcturus Therapeutics, BioNTech, CureVac, Ethris, Immorna, Moderna, Providence Therapeutics and Suzhou Abogen Biosciences
26. September 2024 07:21 ET
|
Research and Markets
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "mRNA Vaccine and Therapeutics Market Industry Trends and Global Forecasts to 2035: Distribution by Application Area, Target Disease Indication and...